{
    "clinical_study": {
        "@rank": "8463", 
        "brief_summary": {
            "textblock": "OBJECTIVES: I. Determine whether allelic differences associated with the fourth component of\n      complement, type-1 complement receptor expressed on erythrocytes, and Fc receptor FcgRIII\n      contribute to the pathogenesis of IgA glomerulonephritis (IgA-N).\n\n      II. Compare genetic anomalies of these key components in immune complex processing and\n      clearance between juvenile vs adult onset IgA-N vs normal controls."
        }, 
        "brief_title": "Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA Glomerulonephritis", 
        "condition": "IGA Glomerulonephritis", 
        "condition_browse": {
            "mesh_term": [
                "Glomerulonephritis", 
                "Glomerulonephritis, IGA"
            ]
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE:\n\n      Participants undergo qualitative genetic analysis of complement-related proteins.  Studies\n      include:  genomic re-arrangement of 4-gene unit, C4 DNA sequence and RNA expression, type-1\n      complement receptor DNA sequence, Fc-gamma receptor IIIA isoform analysis, classical and\n      alternative complement activation pathway assays, plasma C4 and C4d protein levels, and\n      immunoglobulin patterns in glomerular deposits."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  IgA glomerulonephritis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": "105", 
        "firstreceived_date": "October 18, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004305", 
            "org_study_id": "199/11791", 
            "secondary_id": "OSU-94H0338"
        }, 
        "keyword": [
            "IgA glomerulonephritis", 
            "rare disease", 
            "renal and genitourinary disorders"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Columbus", 
                    "country": "United States", 
                    "state": "Ohio"
                }, 
                "name": "Ohio State University"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "overall_official": {
            "affiliation": "Ohio State University", 
            "last_name": "Lee A. Hebert", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004305"
        }, 
        "source": "National Center for Research Resources (NCRR)", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", 
                    "agency_class": "NIH"
                }, 
                {
                    "agency": "Ohio State University", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "National Center for Research Resources (NCRR)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "January 1998", 
        "study_design": "Primary Purpose: Screening", 
        "study_type": "Observational", 
        "verification_date": "April 2002"
    }, 
    "geocoordinates": {
        "Ohio State University": "39.961 -82.999"
    }
}